Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pruritus × Lidocaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Dermatologic 1

Conditions

Breast Neoplasms 13 Neoplasms 12 Pain 11 Pain, Postoperative 9 Colorectal Neoplasms 9 Lung Neoplasms 7 Prostatic Neoplasms 6 Cancer Pain 5 Agnosia 5 Neuralgia 4 Keratosis, Actinic 4 Liver Neoplasms 3 Head and Neck Neoplasms 3 Colonic Neoplasms 3 Chronic Pain 3 Stomatitis 2 Stomach Neoplasms 2 Recurrence 2 Oropharyngeal Neoplasms 2 Myofibroma 2 Mucositis 2 Leiomyoma 2 Ileus 2 Carcinoma, Non-Small-Cell Lung 2 Wounds and Injuries 1 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Tuberculosis 1 Supratentorial Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1

Interventions

tofacitinib 4 Aprepitant 3 masitinib 2 desloratadine 1 apremilast 1 Lidocaine 1 Etanercept 1 Capsules 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00863395 2014-03-31

CTCL

University of Minnesota

Phase 1/2 Terminated

DermatologicLymphoid

Pruritus, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡